BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1528133)

  • 21. Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
    Rees MC; Kuhl H; Engelstein M; Mattila L; Mäenpää J; Mustonen M;
    Climacteric; 2004 Mar; 7(1):23-32. PubMed ID: 15259280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women.
    Oosterbaan HP; van Buuren AH; Schram JH; van Kempen PJ; Ubachs JM; van Leusden HA; Beyer GP
    Maturitas; 1995 Apr; 21(3):211-9. PubMed ID: 7616870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
    Lübbert H; Nauert C
    Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy by the transdermal administration of oestradiol and norethisterone.
    Norman-Taylor JQ; Crawford FE; Jenkins AW; Grudzinskas JG
    Maturitas; 1994 Mar; 18(3):221-8. PubMed ID: 8015505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium.
    Byrjalsen I; Alexandersen P; Christiansen C
    BJOG; 2000 Mar; 107(3):347-55. PubMed ID: 10740331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norethindrone acetate and estradiol-induced endometrial hyperplasia.
    Kurman RJ; Félix JC; Archer DF; Nanavati N; Arce J; Moyer DL
    Obstet Gynecol; 2000 Sep; 96(3):373-9. PubMed ID: 10960628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect on endometrium of combined oestrogen-progestogen replacement therapy of 1 mg 17beta-estradiol and 0.5 mg norethisterone acetate.
    Iatrakis G; Tsionis C; Antoniadis S; Kourounis G
    Clin Exp Obstet Gynecol; 2004; 31(1):50-2. PubMed ID: 14998189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
    Portman DJ; Symons JP; Wilborn W; Kempfert NJ
    Am J Obstet Gynecol; 2003 Feb; 188(2):334-42. PubMed ID: 12592236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women.
    Bouchard P; De Cicco-Nardone F; Spielmann D; Garcea N;
    Gynecol Endocrinol; 2005 Sep; 21(3):142-8. PubMed ID: 16353319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.
    Fraser DI; Parsons A; Whitehead MI; Wordsworth J; Stuart G; Pryse-Davies J
    Fertil Steril; 1990 Mar; 53(3):460-8. PubMed ID: 2407564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations.
    Mattsson LA; Bohnet HG; Gredmark T; Torhorst J; Hornig F; Hüls G
    Obstet Gynecol; 1999 Jul; 94(1):61-5. PubMed ID: 10389719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective randomized controlled study comparing the morphological and biochemical responses of the endometrium to two different forms of 'period-free' hormone replacement therapy.
    Okon MA; Lee S; Laird SM; Li TC
    Hum Reprod; 1998 Aug; 13(8):2261-5. PubMed ID: 9756307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
    Hillard TC; Siddle NC; Whitehead MI; Fraser DI; Pryse-Davies J
    Am J Obstet Gynecol; 1992 Jul; 167(1):1-7. PubMed ID: 1442905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.